JP2005530703A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530703A5
JP2005530703A5 JP2003573013A JP2003573013A JP2005530703A5 JP 2005530703 A5 JP2005530703 A5 JP 2005530703A5 JP 2003573013 A JP2003573013 A JP 2003573013A JP 2003573013 A JP2003573013 A JP 2003573013A JP 2005530703 A5 JP2005530703 A5 JP 2005530703A5
Authority
JP
Japan
Prior art keywords
lactalbumin
complex according
variant
complex
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003573013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530703A (ja
Filing date
Publication date
Priority claimed from GBGB0205347.8A external-priority patent/GB0205347D0/en
Application filed filed Critical
Publication of JP2005530703A publication Critical patent/JP2005530703A/ja
Publication of JP2005530703A5 publication Critical patent/JP2005530703A5/ja
Abandoned legal-status Critical Current

Links

JP2003573013A 2002-03-07 2003-03-07 生物学的に活性な複合体 Abandoned JP2005530703A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205347.8A GB0205347D0 (en) 2002-03-07 2002-03-07 Biologically active complex
PCT/IB2003/001293 WO2003074547A2 (en) 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Publications (2)

Publication Number Publication Date
JP2005530703A JP2005530703A (ja) 2005-10-13
JP2005530703A5 true JP2005530703A5 (cg-RX-API-DMAC10.html) 2006-04-20

Family

ID=9932477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003573013A Abandoned JP2005530703A (ja) 2002-03-07 2003-03-07 生物学的に活性な複合体

Country Status (6)

Country Link
US (1) US20050085416A1 (cg-RX-API-DMAC10.html)
EP (1) EP1485413A2 (cg-RX-API-DMAC10.html)
JP (1) JP2005530703A (cg-RX-API-DMAC10.html)
AU (1) AU2003214522A1 (cg-RX-API-DMAC10.html)
GB (1) GB0205347D0 (cg-RX-API-DMAC10.html)
WO (1) WO2003074547A2 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
WO2005082406A1 (en) * 2004-02-26 2005-09-09 Hamlet Pharma Ab Lactalbumin for inhibiting angiogenesis
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
DK2385954T3 (da) 2009-01-09 2013-06-17 Hamlet Pharma Ab Kompleks og fremstillingsproces
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
DK2643010T3 (en) 2010-11-24 2017-02-27 Hamlet Pharma Ab BIOLOGICAL ACTIVE COMPLEX AND ITS PREPARATION
WO2014023976A1 (en) * 2012-08-09 2014-02-13 Hamlet Pharma Ab Prophylactic and nutraceutical therapy
WO2016133991A1 (en) 2015-02-17 2016-08-25 Xylem Ip Uk Sarl Technique for temperature controlling polarimeter sample cells
IT201700104446A1 (it) * 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility
GB202015836D0 (en) * 2020-10-06 2020-11-18 Hamlet Pharma Ab Compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286860T3 (es) * 1997-11-21 2007-12-01 Nya Hamlet Pharma Ab Proceso de produccion de lactoalbumina.

Similar Documents

Publication Publication Date Title
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
NO20050896L (no) Probiotika for neuromuskulaere funksjoner i tarmen
WO2002024883A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
JP2006506942A5 (cg-RX-API-DMAC10.html)
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
CA2329800A1 (en) Protein formulations
WO2004074486A3 (en) Fusion proteins of interferon alpha muteins with improved properties
JP2006516571A5 (cg-RX-API-DMAC10.html)
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
BR0213821A (pt) Conjugados de polìmero/peptìdeo timosina alfa 1
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
JP2006500321A5 (cg-RX-API-DMAC10.html)
WO2003074547A3 (en) Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
JP2007524708A5 (cg-RX-API-DMAC10.html)
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
EP1243595A4 (en) BH4 FUSIONED POLYPEPTIDES
JP2007533728A5 (cg-RX-API-DMAC10.html)
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
WO2007027092A3 (en) Oral composition for moisturising skin
WO2004032863A3 (en) Oral formulations for proteins and polypeptides
TW200612975A (en) Permucosal composition and method of improving permucosal absorption
GEP20063819B (en) Orodispersible pharmaceutical composition comprising piribedil
JP2001213792A5 (cg-RX-API-DMAC10.html)
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa